Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.43 |
| ▸ | BACE1 | P56817 | 10/20 | 0.43 |
| ▸ | CTSD | P07339 | 2/20 | 0.43 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16565961 | 0.93 | DPP4 (0.55) | DPP4DPP8DPP9FOLH1BACE1 | |
| SCHEMBL30091426 | 0.91 | DPP4 (0.46) | DPP4DPP8DPP9FOLH1BACE1 | |
| SCHEMBL16897943 | 0.86 | CAPN1 (0.41) | CAPN1 | |
| SCHEMBL4232298 | 0.86 | CAPN1 (0.41) | CAPN1 | |
| SCHEMBL13039705 | 0.86 | CAPN1 (0.41) | CAPN1 | |
| SCHEMBL31195712 | 0.85 | FOLH1 (0.60) | DPP4DPP8DPP9FOLH1BACE1 | |
| SCHEMBL29796607 | 0.85 | FOLH1 (0.60) | DPP4DPP8DPP9FOLH1BACE1 | |
| SCHEMBL30784907 | 0.85 | FOLH1 (0.60) | DPP4DPP8DPP9FOLH1BACE1 | |
| SCHEMBL16566020 | 0.84 | DPP8 (0.42) | DPP4DPP8DPP9CAPN1 | |
| SCHEMBL29655260 | 0.83 | FOLH1 (0.63) | DPP4DPP8DPP9FOLH1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160207957-A1 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2016-07-21 | — | — | US | disclosed |
| WO-2015028966-A2 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2015-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160207957-A1 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | PTMS, PEPD, VIP | DPP4 95/4885DPP8 151/4885DPP9 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.